HCPCS Level IIdrugActive
J2777
Inj, faricimab-svoa, 0.1mg
BETOS: O1E
Effective: 2022-10-01
Referenced in 1 policies
Description
Injection, faricimab-svoa, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vabysmo
Manufacturer
Genentech, Inc.
HCPCS Dosage
0.1 MG
Billing Units
60.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.